Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) was the target of a large decline in short interest during the month of July. As of July 15th, there was short interest totalling 79,700 shares, a decline of 12.1% from the June 30th total of 90,700 shares. Based on an average trading volume of 134,500 shares, the days-to-cover ratio is currently 0.6 days.
Coloplast A/S Stock Up 0.8 %
CLPBY traded up $0.10 during trading hours on Wednesday, hitting $12.96. 44,062 shares of the stock were exchanged, compared to its average volume of 55,532. The stock has a 50-day simple moving average of $12.38 and a 200-day simple moving average of $12.64. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.39 and a current ratio of 0.60. Coloplast A/S has a 12 month low of $9.90 and a 12 month high of $14.34.
Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) last posted its quarterly earnings results on Tuesday, May 7th. The company reported $0.08 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.08. Coloplast A/S had a net margin of 19.45% and a return on equity of 36.74%. The company had revenue of $959.05 million for the quarter. Sell-side analysts anticipate that Coloplast A/S will post 0.34 earnings per share for the current fiscal year.
Coloplast A/S Cuts Dividend
Coloplast A/S Company Profile
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.
Recommended Stories
- Five stocks we like better than Coloplast A/S
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Joby Aviation Stock: The Case for Upside Just Got Stronger
- Profitably Trade Stocks at 52-Week Highs
- Conviction Firms for Microsoft’s Double-Digit Stock Upside
- Trading Stocks: RSI and Why it’s Useful
- 5 Aggressive Growth Stocks for Long-Term Investors
Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.